A relapsed leukemia patient taking part in the cellular immunotherapy Phase I cancer trial at Seattle Children's Hospital was deemed free of leukemia cells after about seven months of treatment. The trial is testing the effectiveness of modifying the function of T-cells from the patient's own blood so that they attack the cancer cells. Findings showed that the patient "has had a positive response to the T-cell therapy and, at this time, we do not detect any leukemia cells," lead investigator Dr. Rebecca Gardner said.
Immunotherapy successfully fights leukemia in relapsed patient
SmartBrief Job Listings for Health Care
|Vice President - Government Products||
Health Alliance Plan
|Director, Compliance - Health Plan Privacy & Security||
|Chief Medical Officer||
VANDERBILT HEALTH AFFILIATE NETWORK
|Commercial Health Insurance Strategist__Job #52-14||
American Academy of Family Physicians
|Manager of Payer Relations||
Pharmacy Quality Solutions, Inc.